#162066

Anti-CD20 canine [NCD-1.2]

Cat. #162066

Anti-CD20 canine [NCD-1.2]

Cat. #: 162066

Sub-type: Primary antibody

Target: canine CD20

Class: Monoclonal

Reactivity: Dog

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Moravian Biotechnology

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-CD20 canine [NCD-1.2]
  • Clone: NCD-1.2
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 33-37 kDa (based on literature)
  • Reactivity: Dog
  • Host: Mouse
  • Description: Antibody created to detect canine CD20, epitope NCDPANP (the human NCEPANP is not recognised).
  • Immunogen: NCDPANPSEKNSLSIQYCGSIR of canine CD20
  • Isotype: IgG1 kappa
  • Production details: B cell donor: Splenocytes from mouse immunised with peptide NCDPANPSEKNSLSIQYCGSIR. Fusion partner: SP2.

Target Details

  • Target: canine CD20
  • Molecular weight: 33-37 kDa (based on literature)
  • Target background: CD20 is a transmembrane phosphoprotein that is expressed on the surface of malignant and normal B lymphocytes. As CD20 expression is restricted to B cells, this antigen is a useful marker or target for B-cell lymphomas. Studies demonstrate that the expression of CD20 correlates with B-cell lymphoma in dogs.
  • Epitope sequence: NCDPANPSEKNSLSIQYCGSIR

Handling

  • Format: Liquid

References

  • PMID: 33284343